WBI Investments Inc. Trims Holdings in Danaher Co. (NYSE:DHR)
WBI Investments Inc. trimmed its holdings in Danaher Co. (NYSE:DHR) by 4.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 45,434 shares of the conglomerate’s stock after selling 2,361 shares during the period. WBI Investments Inc.’s holdings in Danaher were worth $4,484,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also bought and sold shares of DHR. Private Capital Group LLC boosted its holdings in shares of Danaher by 445.0% during the 1st quarter. Private Capital Group LLC now owns 1,744 shares of the conglomerate’s stock valued at $171,000 after acquiring an additional 1,424 shares in the last quarter. People s United Financial Inc. raised its position in Danaher by 1.5% during the 2nd quarter. People s United Financial Inc. now owns 176,603 shares of the conglomerate’s stock worth $17,427,000 after purchasing an additional 2,586 shares during the last quarter. Janney Montgomery Scott LLC raised its position in Danaher by 3.5% during the 2nd quarter. Janney Montgomery Scott LLC now owns 111,591 shares of the conglomerate’s stock worth $11,012,000 after purchasing an additional 3,755 shares during the last quarter. Pratt Collard Advisory Partners LLC raised its position in Danaher by 3.8% during the 2nd quarter. Pratt Collard Advisory Partners LLC now owns 17,586 shares of the conglomerate’s stock worth $1,735,000 after purchasing an additional 650 shares during the last quarter. Finally, Achmea Investment Management B.V. raised its position in Danaher by 973.5% during the 2nd quarter. Achmea Investment Management B.V. now owns 22,189 shares of the conglomerate’s stock worth $2,188,000 after purchasing an additional 20,122 shares during the last quarter. 76.95% of the stock is owned by hedge funds and other institutional investors.
In other news, SVP Robert S. Lutz sold 14,555 shares of the company’s stock in a transaction dated Tuesday, July 24th. The shares were sold at an average price of $103.93, for a total transaction of $1,512,701.15. Following the completion of the transaction, the senior vice president now directly owns 18,044 shares of the company’s stock, valued at $1,875,312.92. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP William K. Daniel sold 103,086 shares of the stock in a transaction dated Friday, August 10th. The stock was sold at an average price of $100.63, for a total transaction of $10,373,544.18. Following the completion of the transaction, the executive vice president now directly owns 167,080 shares of the company’s stock, valued at $16,813,260.40. The disclosure for this sale can be found here. Insiders sold 299,961 shares of company stock valued at $30,619,691 over the last quarter. 11.90% of the stock is owned by company insiders.
Danaher (NYSE:DHR) last released its quarterly earnings results on Thursday, July 19th. The conglomerate reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.09 by $0.06. Danaher had a net margin of 13.84% and a return on equity of 11.55%. The firm had revenue of $4.98 billion for the quarter, compared to analysts’ expectations of $4.91 billion. During the same quarter in the prior year, the firm posted $0.99 earnings per share. The business’s quarterly revenue was up 10.4% on a year-over-year basis. research analysts predict that Danaher Co. will post 4.49 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 26th. Investors of record on Friday, September 28th will be given a $0.16 dividend. The ex-dividend date of this dividend is Thursday, September 27th. This represents a $0.64 annualized dividend and a yield of 0.60%. Danaher’s dividend payout ratio (DPR) is presently 15.88%.
Several brokerages recently issued reports on DHR. Zacks Investment Research lowered Danaher from a “buy” rating to a “hold” rating in a research report on Tuesday, July 24th. Morgan Stanley lifted their price objective on Danaher from $120.00 to $122.00 and gave the stock an “overweight” rating in a research report on Friday, July 20th. Royal Bank of Canada lifted their price objective on Danaher to $107.00 and gave the stock a “positive” rating in a research report on Thursday, July 19th. They noted that the move was a valuation call. Bank of America set a $113.00 target price on Danaher and gave the company a “buy” rating in a research note on Thursday, July 19th. Finally, ValuEngine upgraded Danaher from a “hold” rating to a “buy” rating in a research note on Thursday, July 12th. Two equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $109.20.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Featured Article: How do investors use RSI to grade stocks?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.